Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Q&A: Serialisation Legislation

The forthcoming Falsified Medicines Directive aims to combat counterfeiting in Europe, but meeting these regulations will prove a challenge for many. In an interview with IPT, Bruno Cambounet at Axway Emea joins the debate.

Bruno Cambounet, Axway Emea (June 2013)

Keywords: Falsified Medicines Directive GS1 Healthcare Track and Trace ePedigree

    View full article    |    Back to Industry Insight section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |